Tue, January 16, 2024

David Amsellem Maintained (AXSM) at Buy with Increased Target to $113 on, Jan 16th, 2024

David Amsellem of Piper Sandler, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $90 to $113 on, Jan 16th, 2024.

David has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $108 on, Wednesday, December 20th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $100 on, Monday, September 25th, 2023